Patents Assigned to Neogenesis Pharmaceuticals, Inc.
  • Publication number: 20040038993
    Abstract: The invention relates to the inhibition of hepatitis C virus (HCV) replication. In particular, embodiments of the invention provide compounds and methods for inhibiting HCV RNA-dependent RNA polymerase enzymatic activity. The invention also provides compositions and methods for the prophylaxis and treatment of HCV infection.
    Type: Application
    Filed: June 2, 2003
    Publication date: February 26, 2004
    Applicant: Neogenesis Pharmaceuticals, Inc.
    Inventors: Gerald W. Shipps, Kristin E. Rosner, Janeta Popovici-Muller, Yongqi Deng, Tong Wang, Patrick J. Curran
  • Publication number: 20030138788
    Abstract: The present invention provides a method for producing a mass-coded combinatorial library comprising a set of compounds having the general formula X(Y)n, where X is a scaffold, each Y is, independently, a peripheral moiety, and n is an integer greater than 1. The method comprises selecting a peripheral moiety precursor subset from a peripheral moiety precursor set. The subset includes a sufficient number of peripheral moiety precursors that at least about 50 distinct combinations of n peripheral moieties derived from the peripheral moiety precursors in the subset exist. The subset of peripheral moiety precursors is selected so that at least about 90% of all possible combinations of n peripheral moieties derived from the subset have a molecular mass sum which is distinct from the molecular mass sums of all of the other combinations of n peripheral moieties. The method further comprises contacting the peripheral moiety precursor subset with a scaffold precursor which has n reactive groups.
    Type: Application
    Filed: April 19, 2002
    Publication date: July 24, 2003
    Applicant: NeoGenesis Pharmaceuticals, Inc.
    Inventors: Krishna Kalghatgi, Satish Jindal
  • Patent number: 6581013
    Abstract: A technique for automatically analyzing mass spectrographic data from mixtures of chemical compounds has a series of screens designed to eliminate or reduce incorrect peak identifications due to background noise, system resolution, system contamination, multiply charged ions and isotope substitutions. With such a technique, mass spectrograph data analysis may be greatly simplified by the identification of probable spurious signals, and analysis will become simpler and more accurate.
    Type: Grant
    Filed: July 31, 2000
    Date of Patent: June 17, 2003
    Assignee: Neogenesis Pharmaceuticals, Inc.
    Inventors: D. Allen Annis, Mark Birnbaum, Seth N. Birnbaum, Andrew N. Tyler
  • Publication number: 20020182714
    Abstract: The present invention provides a method for producing a mass-coded combinatorial library comprising a set of compounds having the general formula X(Y)n, where X is a scaffold, each Y is, independently, a peripheral moiety, and n is an integer greater than 1. The method comprises selecting a peripheral moiety precursor subset from a peripheral moiety precursor set. The subset includes a sufficient number of peripheral moiety precursors that at least about 50 distinct combinations of n peripheral moieties derived from the peripheral moiety precursors in the subset exist. The subset of peripheral moiety precursors is selected so that at least about 90% of all possible combinations of n peripheral moieties derived from the subset have a molecular mass sum which is distinct from the molecular mass sums of all of the other combinations of n peripheral moieties. The method further comprises contacting the peripheral moiety precursor subset with a scaffold precursor which has n reactive groups.
    Type: Application
    Filed: April 26, 2002
    Publication date: December 5, 2002
    Applicant: NeoGenesis Pharmaceuticals, Inc.
    Inventors: Seth Birnbaum, Edward A. Wintner
  • Publication number: 20020172970
    Abstract: The present invention provides a method for producing a mass-coded combinatorial library comprising a set of compounds having the general formula X(Y)n, where X is a scaffold, each Y is, independently, a peripheral moiety, and n is an integer greater than 1. The method comprises selecting a peripheral moiety precursor subset from a peripheral moiety precursor set. The subset includes a sufficient number of peripheral moiety precursors that at least about 50 distinct combinations of n peripheral moieties derived from the peripheral moiety precursors in the subset exist. The subset of peripheral moiety precursors is selected so that at least about 90% of all possible combinations of n peripheral moieties derived from the subset have a molecular mass sum which is distinct from the molecular mass sums of all of the other combinations of n peripheral moieties. The method further comprises contacting the peripheral moiety precursor subset with a scaffold precursor which has n reactive groups.
    Type: Application
    Filed: April 24, 2002
    Publication date: November 21, 2002
    Applicant: NeoGenesis Pharmaceuticals, Inc.
    Inventor: Krishna Kalghatgi
  • Publication number: 20020164617
    Abstract: The invention relates to methods based on affinity selection for the identification of ligands for hydrophobic proteins bound by amphiphile. The invention also provides hydrophobic proteins and methods of isolation of hydrophobic proteins that are suitable for ligand screening.
    Type: Application
    Filed: December 19, 2001
    Publication date: November 7, 2002
    Applicant: NeoGenesis Pharmaceuticals, Inc.
    Inventors: Jason S. Felsch, David Allen Annis, Krishna Kalghatgi, Huw M. Nash
  • Publication number: 20020115106
    Abstract: The invention relates to methods for forming combinatorial libraries. The invention provides methods suitable for the rapid and convenient synthesis of very large combinatorial libraries of small organic molecules. In particular, the invention provides a method for forming combinatorial libraries combining amide, sulfonamide, or urea bond formation with reductive amination.
    Type: Application
    Filed: December 20, 2001
    Publication date: August 22, 2002
    Applicant: NeoGenesis Pharmaceuticals, Inc.
    Inventors: Gerald W. Shipps, Kollol Pal